Maxim Grymonprez

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 13

Top Topics

Venous Thromboembolism

Cognitive Impairment

Atrial Fibrillation

Oral Anticoagulants

Top Venues

Cardiovascular drugs and therapy

British journal of clinical pharmacology

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Maxim Grymonprez, Mirko Petrovic, Tine L De Backer, M Arfan Ikram, Stephane Steurbaut, Lies Lahousse
Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study. Age and ageing 52 (3) (2023)
Maxim Grymonprez, Stephane Steurbaut, Andreas Capiau, Delphine Vauterin, Frauke Van Vaerenbergh, Els Mehuys, Koen Boussery, Tine L De Backer, Lies Lahousse
Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study. Cardiovascular drugs and therapy (2023)
Maxim Grymonprez, Andreas Capiau, Stephane Steurbaut, Koen Boussery, Els Mehuys, Annemie Somers, Mirko Petrovic, Tine L De Backer, Lies Lahousse
Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study. Cardiovascular drugs and therapy (2023)
Maxim Grymonprez, Laura Carnoy, Andreas Capiau, Koen Boussery, Els Mehuys, Tine L De Backer, Stephane Steurbaut, Lies Lahousse
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study. European heart journal. Cardiovascular pharmacotherapy (2023)
Maxim Grymonprez, Mirko Petrovic, Tine L De Backer, Stephane Steurbaut, Lies Lahousse
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Thrombosis and haemostasis (2023)
Maxim Grymonprez, Mirko Petrovic, Tine L De Backer, Stephane Steurbaut, Lies Lahousse
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study. European heart journal. Quality of care & clinical outcomes (2023)
Maxim Grymonprez, Kevin Vanspranghe, Andreas Capiau, Koen Boussery, Stephane Steurbaut, Lies Lahousse
Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A meta-analysis. British journal of clinical pharmacology 88 (7) (2022)
Maxim Grymonprez, Cynthia Simoens, Stephane Steurbaut, Tine L De Backer, Lies Lahousse
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 24 (6) (2022)
Maxim Grymonprez, Tine L De Backer, Andreas Capiau, Delphine Vauterin, Els Mehuys, Koen Boussery, Stephane Steurbaut, Lies Lahousse
Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study. British journal of clinical pharmacology (2022)
Maxim Grymonprez, Kevin Vanspranghe, Stephane Steurbaut, Tine L De Backer, Lies Lahousse
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis. Cardiovascular drugs and therapy (2021)
Maxim Grymonprez, Andreas Capiau, Tine L De Backer, Stephane Steurbaut, Koen Boussery, Lies Lahousse
The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradox. Clinical cardiology 44 (5) (2021)
Maxim Grymonprez, Tine L De Backer, Stephane Steurbaut, Koen Boussery, Lies Lahousse
Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-Analysis. Cardiovascular drugs and therapy (2021)
Maxim Grymonprez, Stephane Steurbaut, An De Sutter, Lies Lahousse
Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis. Open heart 7 (2) (2021)